Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
64
PDEX Quote, Financials, Valuation and Earnings
Last price:
$38.33
Seasonality move
:
10.49%
Day range:
$37.52 - $38.88
52-week range:
$23.47 - $70.26
Dividend yield:
0%
P/E ratio:
11.48x
P/S ratio:
1.83x
P/B ratio:
3.02x
Volume:
29K
Avg. volume:
32.1K
1-year change:
-17.69%
Market cap:
$125.5M
Revenue:
$66.6M
EPS (TTM):
$3.35
Analysts' Opinion
-
Consensus RatingPro-Dex, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $56.00, Pro-Dex, Inc. has an estimated upside of 45.53% from its current price of $38.48.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $56.00 representing 100% downside risk from its current price of $38.48.
Fair Value
-
According to the consensus of 1 analyst, Pro-Dex, Inc. has 45.53% upside to fair value with a price target of $56.00 per share.
PDEX vs. S&P 500
-
Over the past 5 trading days, Pro-Dex, Inc. has underperformed the S&P 500 by -5.87% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Pro-Dex, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Pro-Dex, Inc. has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Pro-Dex, Inc. reported revenues of $18.5M.
Earnings Growth
-
Pro-Dex, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Pro-Dex, Inc. reported earnings per share of $1.40.
Enterprise value:
129.3M
EV / Invested capital:
--
Price / LTM sales:
1.83x
EV / EBIT:
11.99x
EV / Revenue:
1.84x
PEG ratio (5yr expected):
0.10x
EV / Free cash flow:
-59.52x
Price / Operating cash flow:
95.43x
Enterprise value / EBITDA:
10.74x
Gross Profit (TTM):
$20.4M
Return On Assets:
18.26%
Net Income Margin (TTM):
15.94%
Return On Equity:
31.77%
Return On Invested Capital:
21.61%
Operating Margin:
16.78%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $46.9M | $56.8M | $70.2M | $14.9M | $18.5M | |
| Gross Profit | $13.6M | $16.3M | $20.4M | $5.2M | $5.7M | |
| Operating Income | $6.6M | $8.4M | $10.8M | $3M | $3.1M | |
| EBITDA | $7.6M | $9.5M | $12M | $3.3M | $3.4M | |
| Diluted EPS | $2.08 | $1.53 | $3.35 | $0.75 | $1.40 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $25.8M | $31.2M | $30.8M | $38.3M | $50.7M | |
| Total Assets | $41.9M | $48M | $49.6M | $54.3M | $64.3M | |
| Current Liabilities | $6.2M | $11.7M | $8.3M | $11.3M | $13.6M | |
| Total Liabilities | $20.5M | $23.5M | $18.4M | $23.4M | $22.8M | |
| Total Equity | $21.4M | $24.4M | $31.2M | $30.9M | $41.5M | |
| Total Debt | $14.8M | $15.2M | $12.9M | $14.5M | $13.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $3M | $7.7M | -$1.3M | $1.9M | $2.3M | |
| Cash From Investing | -$921K | -$2.5M | $95K | -$431K | -$98K | |
| Cash From Financing | -$2.9M | -$4M | -$1.4M | -$1M | -$2.1M | |
| Free Cash Flow | $2M | $6.4M | -$2.2M | $1.5M | $2.2M | |
PDEX
Sector
Market Cap
$125.5M
$28.1M
Price % of 52-Week High
54.77%
50%
Dividend Yield
0%
0%
Shareholder Yield
0.88%
-1.54%
1-Year Price Total Return
-17.69%
-17.67%
Beta (5-Year)
-0.051
0.503
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$39.89
200-day SMA
Sell
Level
$42.54
Bollinger Bands (100)
Buy
Level
30.39 - 42.55
Chaikin Money Flow
Sell
Level
-139.4K
20-day SMA
Sell
Level
$41.26
Relative Strength Index (RSI14)
Sell
Level
47.64
ADX Line
Sell
Level
13.65
Williams %R
Buy
Level
-90.309
50-day SMA
Buy
Level
$35.76
MACD (12, 26)
Buy
Level
10.79
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Sell
Level
-249.1K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.2393)
Buy
CA Score
(Annual)
Level (1.1448)
Sell
Beneish M-Score
(Annual)
Level (-1.6307)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.0892)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The firm specializes in medical devices and services, industrial and scientific, dental and component, repairs and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.
Stock Forecast FAQ
In the current month, PDEX has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PDEX average analyst price target in the past 3 months is $56.00.
-
Where Will Pro-Dex, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Pro-Dex, Inc. share price will rise to $56.00 per share over the next 12 months.
-
What Do Analysts Say About Pro-Dex, Inc.?
Analysts are divided on their view about Pro-Dex, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Pro-Dex, Inc. is a Sell and believe this share price will drop from its current level to $56.00.
-
What Is Pro-Dex, Inc.'s Price Target?
The price target for Pro-Dex, Inc. over the next 1-year time period is forecast to be $56.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PDEX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Pro-Dex, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of PDEX?
You can purchase shares of Pro-Dex, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Pro-Dex, Inc. shares.
-
What Is The Pro-Dex, Inc. Share Price Today?
Pro-Dex, Inc. was last trading at $38.33 per share. This represents the most recent stock quote for Pro-Dex, Inc.. Yesterday, Pro-Dex, Inc. closed at $38.48 per share.
-
How To Buy Pro-Dex, Inc. Stock Online?
In order to purchase Pro-Dex, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get PDEX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PDEX
Sector
P/E ratio
11.48x
23.88x
PEG ratio
0.10x
-0.01x
P/B ratio
3.02x
1.81x
Price / LTM sales
1.83x
1.59x
Growth Metrics
PDEX
Sector
Revenue growth
24.43%
4.73%
Earnings growth
87.12%
11.11%
Revenue (5-year growth)
13.84%
6.46%
Earnings forecast
$0.50
-$0.18
Profitability
PDEX
Sector
Profitability FY 2025
$19.5M
$3.6M
Return on invested capital
21.61%
-31.77%
Return on assets
18.26%
-28.18%
Return on equity
31.77%
-37.47%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Jan
29
Estimated Next Earnings Date
Jan
29
Balance Sheet
PDEX
Sector
Total cash
$10.6M
$26.3M
Short term investments
$4.2M
$26M
Total assets
$63.2M
$76.9M
Long term debt
$13.8M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 1
Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.
Buy
75
AXSM alert for Jan 1
Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.
Sell
50
NUTX alert for Jan 1
Nutex Health, Inc. [NUTX] is down 9.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
